The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Accelerated atherosclerosis in patients with SLE—mechanisms and management
Open accessAbstract
Rapid-onset cardiovascular disease (CVD) is a major concern for many patients with systemic lupus erythematosus (SLE). Cardiovascular events occur more frequently and with earlier onset in patients with SLE compared with healthy individuals. Traditional risk factors, such as altered lipid levels, aging and smoking, do not fully explain this increased risk of CVD, strongly suggesting that autoimmunity contributes to accelerated atherosclerosis. Altered immune system function is recognized as the primary contributor to both the initiation and progression of atherosclerosis. Multiple manifestations of autoimmunity, including changes in cytokine levels and innate immune responses, autoantibodies, adipokines, dysfunctional lipids, and oxidative stress, could heighten atherosclerotic risk. In addition, multiple SLE therapeutics seem to affect the development and progression of atherosclerosis both positively and negatively. SLE-specific cardiovascular risk factors are beginning to be discovered by several groups, and development of a comprehensive, clinically feasible biomarker panel could be invaluable for identification and treatment of patients at risk of developing accelerated atherosclerosis. Here, we discuss the epidemiology of CVD in SLE and the implications of immune system dysfunction on the development and progression, monitoring and treatment of atherosclerosis in individuals with this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325
Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., Rubin, C. J., Zhao, W., Olsen, S. H., Klinker, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100450 · Cited by 1,241
The bimodal mortality pattern of systemic lupus erythematosus
Urowitz, M. B., Bookman, A. A. M., Koehler, B. E., Gordon, D. A., Smythe, H. A., & Ogryzlo, M. A. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90431-9 · Cited by 1,000
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Immune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
Graham, I. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.024 · Cited by 722
Homocysteine and vascular disease
McCully, K. S. (1996) · Nature Medicine · doi:10.1038/nm0496-386 · Cited by 702
Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., McCune, W. J., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902199 · Cited by 701
Folsom, A. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1333 · Cited by 683
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
Upchurch, G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., & Loscalzo, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17012 · Cited by 668
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez-Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 624
Recent Advances on the Role of Cytokines in Atherosclerosis
Ait-Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 578
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. G., Rairie, J. E., Tracy, R. P., & Kuller, L. H. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<51::aid-anr7>3.0.co;2-d · Cited by 559
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
Caligiuri, G., Nicoletti, A., Poirier, B., & Hansson, G. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci7272 · Cited by 530
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus
Svenungsson, E., Jensen-Urstad, K., Heimbürger, M., Silveira, A., Hamsten, A., de Faire, U., Witztum, J. L., & Frostegård, J. (2001) · Circulation · doi:10.1161/hc4101.097518 · Cited by 500
Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans
Woo, K. S., Chook, P., Lolin, Y. I., Cheung, A. S. P., Chan, L. T., Sun, Y. Y., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1997) · Circulation · doi:10.1161/01.cir.96.8.2542 · Cited by 486
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
Wall, R. T., Harlan, J. M., Harker, L. A., & Striker, G. E. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90175-9 · Cited by 483
B cell depletion reduces the development of atherosclerosis in mice
Ait-Oufella, H., Herbin, O., Bouaziz, J.-D., Binder, C. J., Uyttenhove, C., Laurans, L., Taleb, S., Van Vré, E., Esposito, B., Vilar, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100155 · Cited by 469
Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., & Bond, G. (1993) · Circulation · doi:10.1161/01.cir.87.4.1107 · Cited by 451
McMahon, M., Grossman, J., FitzGerald, J., Dahlin‐Lee, E., Wallace, D. J., Thong, B. Y., Badsha, H., Kalunian, K., Charles, C., Navab, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21976 · Cited by 431
Self-citationCross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Block, J. A., & Sequeira, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05118-7 · Cited by 422
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Symmons, D. P. M., & Gabriel, S. E. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.75 · Cited by 406
Doria, A., Shoenfeld, Y., Wu, R., Gambari, P. F., Puato, M., Ghirardello, A., Gilburd, B., Corbanese, S., Patnaik, M., Zampieri, S., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1071 · Cited by 403
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
Bruce, I. N., Urowitz, M. B., Gladman, D. D., Ibañez, D., & Steiner, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11296 · Cited by 394
Shah, P. K., Yano, J., Reyes, O., Chyu, K.-Y., Kaul, S., Bisgaier, C. L., Drake, S., & Cercek, B. (2001) · Circulation · doi:10.1161/hc2501.092494 · Cited by 381
Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117200 · Cited by 377
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice
Major, A. S., Fazio, S., & Linton, M. F. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000039169.47943.ee · Cited by 329
Toloza, S. M. A., Uribe, A. G., McGwin, G., Alarcón, G. S., Fessler, B. J., Bastian, H. M., Vilá, L. M., Wu, R., Shoenfeld, Y., Roseman, J. M., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20622 · Cited by 319
Vaarala, O., Mänttäri, M., Manninen, V., Tenkanen, L., Puurunen, M., Aho, K., & Palosuo, T. (1995) · Circulation · doi:10.1161/01.cir.91.1.23 · Cited by 317
Hajjar, K. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116532 · Cited by 314
Kyaw, T., Tay, C., Khan, A., Dumouchel, V., Cao, A., To, K., Kehry, M., Dunn, R., Agrotis, A., Tipping, P., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000033 · Cited by 311
OutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305
Jung, H., Bobba, R., Su, J., Shariati‐Sarabi, Z., Gladman, D. D., Urowitz, M., Lou, W., & Fortin, P. R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27289 · Cited by 291
Vascular Stiffness in Women With Systemic Lupus Erythematosus
Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S., Tracy, R., Kuller, L., & Manzi, S. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1075 · Cited by 287
Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., McCune, W. J., & Kaplan, M. J. (2007) · Blood · doi:10.1182/blood-2007-05-089086 · Cited by 282
Systemic Lupus Erythematosus: An Independent Risk Factor for Endothelial Dysfunction in Women
El-Magadmi, M., Bodill, H., Ahmad, Y., Durrington, P. N., Mackness, M., Walker, M., Bernstein, R. M., & Bruce, I. N. (2004) · Circulation · doi:10.1161/01.cir.0000136807.78534.50 · Cited by 276
Stone, N. J., Bilek, S., & Rosenbaum, S. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.006 · Cited by 267
Ehrlich, G. E. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.2.251 · Cited by 261
Rajagopalan, S., Somers, E. C., Brook, R. D., Kehrer, C., Pfenninger, D., Lewis, E., Chakrabarti, A., Richardson, B. C., Shelden, E., McCune, W. J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3198 · Cited by 255
Hansson, G. K., Jonasson, L., Holm, J., Clowes, M. M., & Clowes, A. W. (1988) · Circulation Research · doi:10.1161/01.res.63.4.712 · Cited by 250
Interferon gamma: A master regulator of atherosclerosis
McLaren, J. E., & Ramji, D. P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.003 · Cited by 239
Recio-Mayoral, A., Mason, J. C., Kaski, J. C., Rubens, M. B., Harari, O. A., & Camici, P. G. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp205 · Cited by 235
Lupus Atherosclerosis Prevention Study (LAPS)
Petri, M. A., Kiani, A. N., Post, W., Christopher-Stine, L., & Magder, L. S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.136762 · Cited by 234
Nossent, J., Cikes, N., Kiss, E., Marchesoni, A., Nassonova, V., Mosca, M., Olesinska, M., Pokorny, G., Rozman, B., Schneider, M., et al. (2007) · Lupus · doi:10.1177/0961203307077987 · Cited by 223
Petri, M. (2000) · Lupus · doi:10.1191/096120300678828226 · Cited by 219
Wu, R., Nityanand, S., Berglund, L., Lithell, H., Holm, G., & Lefvert, A. K. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3159 · Cited by 218
McMahon, M., Grossman, J., Skaggs, B., FitzGerald, J., Sahakian, L., Ragavendra, N., Charles‐Schoeman, C., Watson, K., Wong, W. K., Volkmann, E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24677 · Cited by 216
Self-citationRahman, P., Gladman, D. D., Urowitz, M. B., Yuen, K., Hallett, D. C., & Bruce, I. N. (1999) · PubMed · Cited by 199
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus
Roman, M. J., Crow, M. K., Lockshin, M. D., Devereux, R. B., Paget, S. A., Sammaritano, L., Levine, D. M., Davis, A., & Salmon, J. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22924 · Cited by 196
Toma, I., & McCaffrey, T. A. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1189-3 · Cited by 193
Chung, C., Long, A., Solus, J., Rho, Y., Oeser, A., Raggi, P., & Stein, C. (2009) · Lupus · doi:10.1177/0961203309103582 · Cited by 177
Taleb, S., Herbin, O., Ait‐Oufella, H., Verreth, W., Gourdy, P., Barateau, V., Merval, R., Esposito, B., Clément, K., Holvoet, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149567 · Cited by 172
George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J., & Shoenfeld, Y. (2000) · Circulation · doi:10.1161/01.cir.102.15.1822 · Cited by 167
Charles‐Schoeman, C., Watanabe, J., Lee, Y. Y., Fürst, D. E., Amjadi, S., Elashoff, D. A., Park, G. S. H., McMahon, M. A., Paulus, H. E., Fogelman, A. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24802 · Cited by 166
Self-citationFactors associated with coronary artery calcification in young female patients with SLE
Manger, K., Kusus, M., Forster, C., Ropers, D., Daniel, W. G., Kalden, J. R., Achenbach, S., & Manger, B. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.846 · Cited by 155
Charakida, M. (2009) · JAMA · doi:10.1001/jama.2009.1346 · Cited by 152
Schanberg, L. E., Sandborg, C. I., Barnhart, H. X., Ardoin, S. P., Yow, E. S., Evans, G. W., Mieszkalski, K. L., Ilowite, N. T., Eberhard, A., Levy, D. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24469 · Cited by 147
Svenungsson, E., Fei, G.-Z., Jensen‐Urstad, K., Fairé, U. D., Hamsten, A., & Frostegård, J. (2003) · Lupus · doi:10.1191/0961203303lu412oa · Cited by 147
Serum leptin levels in women with systemic lupus erythematosus
García-González, A., González-López, L., Valera, I., Cardona-Muñóz, E. G., Salazar-Páramo, M., González-Ortíz, M., Martínez‐Abundis, E., & Gámez-Nava, J. I. (2002) · Rheumatology International · doi:10.1007/s00296-002-0216-9 · Cited by 141
Nord, J. E., Shah, P. K., Rinaldi, R. Z., & Weisman, M. H. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.09.012 · Cited by 137
Thacker, S. G., Berthier, C. C., Mattinzoli, D., Rastaldi, M. P., Kretzler, M., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001782 · Cited by 137
Li, J., Fu, Q., Cui, H., Qu, B., Pan, W. Q., Shen, N., & Bao, C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30165 · Cited by 136
TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Karlsson, L., Sun, S., Rao, N. L., Venable, J. D., & Thurmond, R. L. (2007) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152807783334300 · Cited by 133
Feldt, J. M. V., Scalzi, L. V., Cucchiara, A. J., Morthala, S., Kealey, C., Flagg, S. D., Genin, A., Dyke, A. L. V., Nackos, E., Chander, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21967 · Cited by 131
Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells
Shin, M. S., Lee, N., & Kang, I. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349a255 · Cited by 127
Ferreira, G. A., Navarro, T. P., Telles, R. W., Andrade, L. E. C., & Sato, E. I. (2007) · Rheumatology · doi:10.1093/rheumatology/kem186 · Cited by 127
Kang, S., Wu, Y., & Li, X. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.005 · Cited by 126
The Inflammation Hypothesis and Its Potential Relevance to Statin Therapy
Forrester, J. S., & Libby, P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.125 · Cited by 126
Bravo, Y., Quiroz, Y., Ferrebuz, A., Vaziri, N. D., & Rodríguez‐Iturbe, B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00507.2006 · Cited by 126
Rho, Y. H., Chung, C. P., Oeser, A. M., Solus, J. F., Raggi, P., Gebretsadik, T. S., Shintani, A., & Stein, C. M. (2008) · PubMed · Cited by 122
O'Neill, S. G., Giles, I., Lambrianides, A., Manson, J. J., D’Cruz, D. P., Schrieber, L., MARCH, L. M., Latchman, D. S., Isenberg, D. A., & Rahman, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27286 · Cited by 115
Regulation of autoreactive B cell responses to endogenous TLR ligands
Avalos, A. M., Busconi, L., & Marshak-Rothstein, A. (2010) · Autoimmunity · doi:10.3109/08916930903374618 · Cited by 114
Duran-Barragán, S., McGwin, G., Vilá, L. M., Reveille, J. D., & Alarcón, G. S. (2008) · Rheumatology · doi:10.1093/rheumatology/ken208 · Cited by 114
Differential effects of regulatory T cells on the initiation and regression of atherosclerosis
Foks, A. C., Frodermann, V., ter Borg, M., Habets, K. L. L., Bot, I., Zhao, Y., Eck, M. V., van Berkel, T. J. C., Kuiper, J., & van Puijvelde, G. H. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.029 · Cited by 113
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
Graham, I. D., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 113
Fequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE
Dinu, A., Merrill, J. T., Shen, C. P., Antonov, I. V., Myones, B. L., & Lahita, R. G. (1998) · Lupus · doi:10.1191/096120398678920262 · Cited by 110
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Lenten, B. J. V., Wagner, A. C., Hama, S. Y., Hough, G., Bachini, E., Garber, D. W., Mishra, V., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000174589.70190.e2 · Cited by 109
Endothelial cell activation by antiphospholipid antibodies
Meroni, P. L., Raschi, E., Testoni, C., & Borghi, M. O. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.015 · Cited by 105
Bruce, I. N., Burns, R. J., Gladman, D., & Mb, U. (2000) · PubMed · Cited by 98
Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms
Avalos, I., Chung, C. P., Oeser, A. M., Milne, G. L., Morrow, J. D., Gebretsadik, T. S., Shintani, A., Yu, C., & Stein, C. M. (2007) · Lupus · doi:10.1177/0961203306075802 · Cited by 98
Haque, S., Gordon, C., Isenberg, D. A., Rahman, A., Lanyon, P., Bell, A. L., Emery, P., McHugh, N. J., Teh, L., Scott, D. G. I., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090306 · Cited by 96
Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D. T., Cervera, R., Doria, A., Jayne, D. R. W., Khamashta, M. A., Kuhn, A., et al. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.12.008 · Cited by 95
Aprahamian, T. R., Bonegio, R. G. B., Rizzo, J. L., Perlman, H., Lefer, D. J., Rifkin, I. R., & Walsh, K. X. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3028 · Cited by 93
Apolipoprotein A-I mimetic peptides
Lenten, B. J. V., Wagner, A. C., Anantharamaiah, G. M., Navab, M., Reddy, S. T., Buga, G. M., & Fogelman, A. M. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0008-8 · Cited by 87
Sabio, J. M., Vargas‐Hitos, J. A., Zamora‐Pasadas, M., Mediavilla, J. D., Navarrete‐Navarrete, N., Ramírez, Á., Hidalgo-Tenorio, C., Jáimez, L., Martin, J. J., & Jiménez-Alonso, J. F. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081253 · Cited by 85
Yazdany, J., Tonner, C., Trupin, L. S., Panopalis, P., Gillis, J. Z., Hersh, A. O., Julian, L. J., Katz, P., Criswell, L. A., & Yelin, E. H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3011 · Cited by 81
Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis
Marder, W., Khalatbari, S. H., Myles, J. D., HENCH, R. P., Yalavarthi, S., Lustig, S., Brook, R. D., & Kaplan, M. J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148031 · Cited by 78
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr−/− mice
van Leuven, S. I., Mendez-Fernandez, Y., Wilhelm, A. J., Wade, N. S., Gabriel, C. L., Kastelein, J. J. P., Stroes, E. S. G., Tak, P. P., & Major, A. S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200071 · Cited by 73
Rúa‐Figueroa, Í., Arencibia‐Mireles, O., Elvira, M. U. R., Erausquin, C., Ojeda, S., Francisco, F., Naranjo, A., Rodríguez‐Gallego, C., García-Laorden, I., Rodríguez-Perez, J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.104349 · Cited by 73
Huang, Q., & Pope, R. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310126 · Cited by 73
Reynolds, H. R., Buyon, J. P., Kim, M., Rivera, T. L., Izmirly, P., Tunick, P. A., & Clancy, R. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.007 · Cited by 72
van Leuven, S. I., van Wijk, D. F., Volger, O. L., de Vries, J. P. P. M., van der Loos, C. M., de Kleijn, D. P. V., Horrevoets, A. J. G., Tak, P. P., van der Wal, A. C., de Boer, O. J., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.043 · Cited by 72
David, K. M., Morris, J. A., Steffen, B. J., et al. (2005) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00338.x · Cited by 72
Homocysteine or Renal Impairment
Potter, K., Hankey, G. J., GREEN, D. J., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162743 · Cited by 69
Adipokines as novel biomarkers in paediatric systemic lupus erythematosus
al., M. A. J. A. E., Ng, L., Tyrrell, P. N., Bargman, J. M., Bradley, T. J., & Silverman, E. D. (2008) · Rheumatology · doi:10.1093/rheumatology/kep030 · Cited by 68
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
Kahlenberg, J. M., & Kaplan, M. J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3264 · Cited by 67
Vuilleumier, N., Reber, G., James, R. W., Burger, D., de Moerloose, P., Dayer, J., & Roux‐Lombard, P. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.08.003 · Cited by 64
Microcirculatory Hemodynamics and Endothelial Dysfunction in Systemic Lupus Erythematosus
Wright, S., O’Prey, F. M., Rea, D. J., Plumb, R., Gamble, A. J., Leahey, W. J., Devine, A. B., McGivern, R. C., Johnston, D., Finch, M. B., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000238351.82900.7f · Cited by 62
Kyaw, T. S., Tipping, P. G., Toh, B., & Bobik, A. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834adaf3 · Cited by 61
Woo, J. M. P., Lin, Z., Navab, M., Dyck, C. V., Trejo-Lopez, Y., Woo, K. M. T., Li, H., Castellani, L. W., Wang, X., Iikuni, N., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3020 · Cited by 54
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus
Costenbader, K. H., Karlson, E. W., Gall, V., de Pablo, P., Finckh, A., Lynch, M., Bermas, B. L., Schur, P. H., & Liang, M. H. (2005) · Arthritis Care & Research · doi:10.1002/art.21441 · Cited by 53
Hyperhomocysteinaemia and Risk of Thrombosis in Systemic Lupus Erythematosus Patients
Refai, T. M. K., Al-Salem, I. H., Nkansa-Dwamena, D., & Al-Salem, M. H. (2002) · Clinical Rheumatology · doi:10.1007/s100670200115 · Cited by 52
Kiani, A. N., Magder, L. S., & Petri, M. (2011) · Rheumatology International · doi:10.1007/s00296-011-2048-y · Cited by 51
von Vietinghoff, S., Koltsova, E. K., Mestas, J., Diehl, C. J., Witztum, J. L., & Ley, K. F. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.030 · Cited by 47
Campbell, L. A., Yaraei, K., Lenten, B. J. V., Chait, A., Blessing, E., Kuo, C., Nosaka, T., Ricks, J. L., & Rosenfeld, M. E. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.04.001 · Cited by 44
Activation of transforming growth factor-β1and early atherosclerosis in systemic lupus erythematosus
Jackson, M., Ahmad, Y. A., Bruce, I. N., Coupes, B. M., & Brenchley, P. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1951 · Cited by 44
Salel, A. F., Fong, A. K. H., ZELIS, R. F., Miller, R. R., Borhani, N. O., & Mason, D. T. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706232962507 · Cited by 42
How does interferon‐α insult the vasculature? Let me count the ways
Kaplan, M. J., & Salmon, J. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30161 · Cited by 36
Fesmire, J., Wolfson‐Reichlin, M., & Reichlin, M. (2010) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042010000500007 · Cited by 28
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome
Gualtierotti, R., Biggioggero, M., & Meroni, P. L. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8268-9 · Cited by 28
Pengo, V., Bison, E., Ruffatti, A., & Iliceto, S. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.12.028 · Cited by 26
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Cited by
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358
The role of B cells in atherosclerosis
Sage, A. P., Tsiantoulas, D., Binder, C. J., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0106-9 · Cited by 298
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): From bench to bedside
Bao, X., Liang, Y., Chang, H., Cai, T., Feng, B., Gordon, K., Zhu, Y., Shi, H., He, Y., & Xie, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01690-3 · Cited by 187
Metadata
- Authors
- Skaggs, B. J., Hahn, B. H., & McMahon, M.
- Venue
- Nature Reviews Rheumatology
- Published
- 2012-02-14
- Volume
- 8
- Issue
- 4
- Pages
- 214-223
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2072693781
- Cited by
- 253
- References
- 123
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.